General Announcement::Press Release

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS GLOBAL PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
15-Apr-2025 11:45:31
Status
New
Announcement Sub Title
Press Release
Announcement Reference
SG250415OTHRI20M
Submitted By (Co./ Ind. Name)
Akhilesh Nand - Biocon Biologics Limited
Designation
Company Secretary
Effective Date and Time of the event
15/04/2025 09:15:00
Description (Please provide a detailed description of the event in the box below)
Biocon Biologics Secures Market Entry Date for Yesafili , an Interchangeable Biosimilar to Eylea , in the U.S.

Attachments

BBL_PR_Yesafili_15042025.pdf
Total size =430K